Literature DB >> 18190331

Clostridium difficile-associated disease treatment response depends on definition of cure.

Steven J Lawrence, Erik R Dubberke, Stuart Johnson, Dale N Gerding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18190331     DOI： 10.1086/523718

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  In vitro and in vivo characterization of CB-183,315, a novel lipopeptide antibiotic for treatment of Clostridium difficile.

Authors:  Carmela T M Mascio; Lawrence I Mortin; Karen T Howland; Andrew D G Van Praagh; Shuxin Zhang; Anu Arya; Cun Lan Chuong; Chunfeng Kang; Tongchuan Li; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

2.  A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection.

Authors:  Tanya M Monaghan; Niharika A Duggal; Elisa Rosati; Ruth Griffin; Jamie Hughes; Brandi Roach; David Y Yang; Christopher Wang; Karen Wong; Lynora Saxinger; Maja Pučić-Baković; Frano Vučković; Filip Klicek; Gordan Lauc; Paddy Tighe; Benjamin H Mullish; Jesus Miguens Blanco; Julie A K McDonald; Julian R Marchesi; Ning Xue; Tania Dottorini; Animesh Acharjee; Andre Franke; Yingrui Li; Gane Ka-Shu Wong; Christos Polytarchou; Tung On Yau; Niki Christodoulou; Maria Hatziapostolou; Minkun Wang; Lindsey A Russell; Dina H Kao
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

3.  Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies.

Authors:  Hemangi B Shah; Kenneth Smith; Edgar J Scott; Jason L Larabee; Judith A James; Jimmy D Ballard; Mark L Lang
Journal:  JCI Insight       Date:  2020-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.